Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
51
datasets available to search
ShareScore release 0.9.0
Dataset results
51 results for “non-muscle-invasive bladder cancer”
BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer
ClinicalTrials.gov study NCT06462001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT01475266. IPD Sharing: Not stated. Countries: 2. Publications: 0.
AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT05002556. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT02720367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT06732531. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
ClinicalTrials.gov study NCT06287541. IPD Sharing: YES. Countries: 1. Publications: 0.
Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT06972771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
ClinicalTrials.gov study NCT04799847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory Culture
ClinicalTrials.gov study NCT04583553. IPD Sharing: NO. Countries: 1. Publications: 0.
Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer
ClinicalTrials.gov study NCT02948543. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy
ClinicalTrials.gov study NCT06351904. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Safety, Tolerability and Response of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)
ClinicalTrials.gov study NCT07260162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
ClinicalTrials.gov study NCT06211764. IPD Sharing: YES. Countries: 14. Publications: 0.
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT06503614. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT07187635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial
ClinicalTrials.gov study NCT03504163. IPD Sharing: Not stated. Countries: 1. Publications: 0.
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT05232136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT06919965. IPD Sharing: YES. Countries: 14. Publications: 0.
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Dep
ClinicalTrials.gov study NCT07036731. IPD Sharing: YES. Countries: 1. Publications: 0.
Thulium Fiber Laser En-bloc Resection vs Conventional Transurethral Resection of Non-muscle-invasive Bladder Cancer
ClinicalTrials.gov study NCT04110483. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.